CAM
AMAM
Cormorant Asset Management’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,231,000
| Closed | -$160M | – | 65 |
|
|
2023
Q4 | $160M | Buy |
11,231,000
+1,307,311
| +13% | +$18.6M | 7.64% | 2 |
|
|
2023
Q3 | $114M | Buy |
9,923,689
+307,534
| +3% | +$3.54M | 6.66% | 3 |
|
|
2023
Q2 | $158M | Buy |
9,616,155
+1,116,155
| +13% | +$18.4M | 8.87% | 2 |
|
|
2023
Q1 | $75.8M | Buy |
8,500,000
+6,163,611
| +264% | +$55M | 4.99% | 5 |
|
|
2022
Q4 | $5.3M | Hold |
2,336,389
| – | – | 0.35% | 54 |
|
|
2022
Q3 | $2.52M | Sell |
2,336,389
-149,997
| -6% | -$162K | 0.18% | 56 |
|
|
2022
Q2 | $6.59M | Hold |
2,486,386
| – | – | 0.5% | 46 |
|
|
2022
Q1 | $10.2M | Hold |
2,486,386
| – | – | 0.79% | 39 |
|
|
2021
Q4 | $22.5M | Hold |
2,486,386
| – | – | 1.34% | 23 |
|
|
2021
Q3 | $33.1M | Hold |
2,486,386
| – | – | 1.34% | 21 |
|
|
2021
Q2 | $47M | Buy |
+2,486,386
| New | +$47M | 1.6% | 15 |
|